| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Endovia Health Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Mo | Endovia Health Sciences: Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway | 122 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. ("Endovia" or the "Company") (NYSE American: EDVA), in association with Lupvindol BioSciences ("Lupvindol"),... ► Artikel lesen | |
| ENDOVIA HEALTH SCIENCES Aktie jetzt für 0€ handeln | |||||
| 23.09. | Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On | 7 | Benzinga.com | ||
| 22.09. | Endovia Health Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.09. | Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil Development Amid Growing Federal Support for Botanical Drug Pathways | 230 | GlobeNewswire (Europe) | Initial tranche assists CannEpil® development and commercialization Financing comes as FDA and Congress increase focus on advancing and incentivizing regulated development of botanical and plant-derived... ► Artikel lesen | |
| 31.08. | Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil FDA Submission and Expands Development Pipeline | 278 | GlobeNewswire (Europe) | Company views federal support for Schedule III as a significant evolution in U.S. cannabinoid policy and an important step toward a durable regulatory framework for cannabinoid-based medicines and... ► Artikel lesen | |
| 25.08. | Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil Veterinary Development Program | 286 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Endovia Health Sciences, Inc. (NYSE American: EDVA), formerly Splash Beverage Group, Inc. (NYSE American: SBEV) ("Endovia Health" or the "Company")... ► Artikel lesen | |
| 25.08. | Endovia Health Sciences, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.08. | Splash Beverage to rename as Endovia Health Sciences; shares up | 1 | Seeking Alpha | ||
| 21.08. | Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker "EDVA" Effective Monday | 376 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company") today announced that its corporate name will change to Endovia Health Sciences... ► Artikel lesen | |
| 20.08. | SPLASH BEVERAGE GROUP, INC. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 20.08. | Splash Beverage Group GAAP EPS of -$2.30 | 1 | Seeking Alpha | ||
| 20.08. | SPLASH BEVERAGE GROUP, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.08. | Splash Beverage Group: Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences | 307 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company") today reported financial results for the second quarter ended... ► Artikel lesen | |
| 19.08. | SPLASH BEVERAGE GROUP, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 17.08. | SPLASH BEVERAGE GROUP, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 12.08. | Splash Beverage will officially become Endovia Health Sciences on August 21 | 1 | Seeking Alpha | ||
| 12.08. | Strategiewechsel: Splash Beverage firmiert in Endovia Health Sciences um | 2 | Investing.com Deutsch | ||
| 12.08. | Splash Beverage to rebrand as Endovia Health Sciences | 1 | Investing.com | ||
| 12.08. | Splash Beverage Group to Rebrand as Endovia Health Sciences | 277 | GlobeNewswire (Europe) | FORT LAUDERDALE, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company") today announced its intention to change its corporate name to Endovia Health... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 41,590 | 0,00 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,720 | 0,00 % | Fresenius Medical Care: Helen Giza verlässt den Konzern - Nachfolger steht fest | Bad Marienberg (www.anleihencheck.de) - Ad hoc-Mitteilung der Fresenius Medical Care AG vom 07.10.2026:Der Aufsichtsrat der Fresenius Medical Care AG hat heute einstimmig beschlossen, Shervin J. Korangy... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,260 | 0,00 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers vor Zahlen zum vierten Geschäftsquartal auf "Hold" mit einem Kursziel von 39 Euro belassen. Er rechne... ► Artikel lesen | |
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | Alignment Healthcare earns 4-Star or higher ratings for six plans | ||
| HEARTFLOW | 47,590 | -0,08 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| OTTOBOCK | 51,80 | 0,00 % | Ottobock SE & Co. KGaA mit BRANDMELDUNG: Verkaufen Insider bereits? - Handeln Sie noch heute! | ||
| CARL ZEISS MEDITEC | 31,060 | 0,00 % | 200-Tage-Linie hält: Goldman verpasst Zeiss Meditec einen Dämpfer | Goldman Sachs stuft Carl Zeiss Meditec auf "Sell" ab und senkt das Kursziel auf 23 Euro. Zwischenzeitlich verlor das Papier gut sieben Prozent, fing sich dann aber knapp über der 200-Tage-Linie. Die... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | -0,04 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | -0,05 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| GERRESHEIMER | 28,420 | 0,00 % | DAX wenig bewegt - BASF, Evonik, Gerresheimer, VW: Was Anleger wissen müssen Video | Markus Königer, Market Making Derivatives Products der ICF BANK AG, fasst die vergangene Handelswoche zusammen. Der DAX präsentiert sich wenig bewegt, was angesichts der hohen Inflation und dem volatile... ► Artikel lesen |